Febutaz 40 Tablet

Febutaz 40 Tablet is a non-purine selective inhibitor, disrupts the activity of xanthine oxidase, a key enzyme in purine breakdown. By forming a stable complex with both forms of the enzyme, febuxostat effectively hinders its function. This inhibition reduces the production of uric acid from hypoxanthine, leading to lower levels of uric acid in the bloodstream. The therapeutic impact of febuxostat lies in its ability to decrease serum uric acid levels in individuals with hyperuricemia, a condition where uric acid concentration exceeds its solubility threshold. Notably, febuxostat's chemical structure differs from purines and pyrimidines, and it appears to specifically target xanthine oxidase without affecting other nucleotide-catabolic enzymes.

• Do not chew it.
• Take proper dose as per doctor’s recommendations.
• Finish the full course for proper effect.

• It's important to discuss this with your healthcare provider, who may prescribe additional medications to prevent or manage these flares during the early stages of treatment.
• Febuxostat is metabolized by the liver Patients with liver impairment may require dosage adjustments or closer monitoring.

• Xanthine oxidase inhibitor for gout management.
• Reduces uric acid levels.
• Prevents gout attacks.
• May improve joint symptoms associated with gout.

• Diarrhea
• Headache
• Increased liver enzymes
• Nausea
• Skin rash